Neoplasms by Site Terminated Phase 3 Trials for Linifanib (DB06080)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0030096 (Neoplasms by Site) | Terminated | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01009593 | Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | Treatment |